Browse hierarchy: [Hematology (HE)](/submissions/HE) → [Subpart I — Hematology Reagents](/submissions/HE/subpart-i%E2%80%94hematology-reagents) → [21 CFR 864.8625](/submissions/HE/subpart-i%E2%80%94hematology-reagents/864.8625) → GFS — Standards And Controls, Hemoglobin, Normal And Abnormal

# GFS · Standards And Controls, Hemoglobin, Normal And Abnormal

_Hematology · 21 CFR 864.8625 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/GFS

## Overview

- **Product Code:** GFS
- **Device Name:** Standards And Controls, Hemoglobin, Normal And Abnormal
- **Regulation:** [21 CFR 864.8625](/submissions/HE/subpart-i%E2%80%94hematology-reagents/864.8625)
- **Device Class:** 2
- **Review Panel:** [Hematology](/submissions/HE)

## Identification

A hematology quality control mixture is a device used to ascertain the accuracy and precision of manual, semiautomated, and automated determinations of cell parameters such as white cell count (WBC), red cell count (RBC), platelet count (PLT), hemoglobin, hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC).

## Classification Rationale

Class II (special controls). Except when intended for use in blood components, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

## Special Controls

*Classification.* Class II (special controls). Except when intended for use in blood components, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K023032](https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/GFS/K023032.md) | LIQUITROL, LIQUID HUMAN GLYCOSYLA,TED HEMOGLOBIN (A1C) CONTROL - NORMAL/ABNORMAL | Bioresource Technology, Inc. | Oct 8, 2002 | SESE |

## Top Applicants

- Bioresource Technology, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/GFS](https://fda.innolitics.com/submissions/HE/subpart-i%E2%80%94hematology-reagents/GFS)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com